Robert M Chapman

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. ncbi The impact of AD drug treatments on event-related potentials as markers of disease conversion
    Robert M Chapman
    Department of Brain and Cognitive Sciences, 775 Library Road, University of Rochester, Rochester, NY 14627, USA
    Curr Alzheimer Res 10:732-41. 2013
  2. pmc C145 as a short-latency electrophysiological index of cognitive compensation in Alzheimer's disease
    Robert M Chapman
    Department of Brain and Cognitive Sciences and Center for Visual Science at the University of Rochester, Rochester, NY 14627, USA
    J Alzheimers Dis 33:55-68. 2013
  3. pmc Women have farther to fall: gender differences between normal elderly and Alzheimer's disease in verbal memory engender better detection of Alzheimer's disease in women
    Robert M Chapman
    Department of Brain and Cognitive Sciences and Center for Visual Science, University of Rochester, Rochester, NY 14627, USA
    J Int Neuropsychol Soc 17:654-62. 2011
  4. pmc Brain event-related potentials: diagnosing early-stage Alzheimer's disease
    Robert M Chapman
    Department of Brain and Cognitive Sciences and Center for Visual Science, University of Rochester, Rochester, NY 14627, USA
    Neurobiol Aging 28:194-201. 2007
  5. pmc Brain ERP components predict which individuals progress to Alzheimer's disease and which do not
    Robert M Chapman
    Department of Brain and Cognitive Sciences and Center for Visual Science at the University of Rochester, Rochester, NY 14627, USA
    Neurobiol Aging 32:1742-55. 2011
  6. pmc Diagnosis of Alzheimer's disease using neuropsychological testing improved by multivariate analyses
    Robert M Chapman
    Brain and Cognitive Sciences and Center for Visual Science, University of Rochester, Rochester, NY 14627 0270, USA
    J Clin Exp Neuropsychol 32:793-808. 2010
  7. pmc Predicting conversion from mild cognitive impairment to Alzheimer's disease using neuropsychological tests and multivariate methods
    Robert M Chapman
    Brain and Cognitive Sciences and Center for Visual Science, University of Rochester, Rochester, NY 14627 0270, USA
    J Clin Exp Neuropsychol 33:187-99. 2011

Research Grants

  1. Cognitive Brain Activity: Aging and Dementia
    Robert Chapman; Fiscal Year: 2007

Detail Information

Publications7

  1. ncbi The impact of AD drug treatments on event-related potentials as markers of disease conversion
    Robert M Chapman
    Department of Brain and Cognitive Sciences, 775 Library Road, University of Rochester, Rochester, NY 14627, USA
    Curr Alzheimer Res 10:732-41. 2013
    ..These results provide practical information to those using ERP measures as a biomarker to identify and track AD in individuals in a clinical or research setting. ..
  2. pmc C145 as a short-latency electrophysiological index of cognitive compensation in Alzheimer's disease
    Robert M Chapman
    Department of Brain and Cognitive Sciences and Center for Visual Science at the University of Rochester, Rochester, NY 14627, USA
    J Alzheimers Dis 33:55-68. 2013
    ....
  3. pmc Women have farther to fall: gender differences between normal elderly and Alzheimer's disease in verbal memory engender better detection of Alzheimer's disease in women
    Robert M Chapman
    Department of Brain and Cognitive Sciences and Center for Visual Science, University of Rochester, Rochester, NY 14627, USA
    J Int Neuropsychol Soc 17:654-62. 2011
    ..The results indicate the LM is a more powerful and reliable tool in detecting AD in women than in men...
  4. pmc Brain event-related potentials: diagnosing early-stage Alzheimer's disease
    Robert M Chapman
    Department of Brain and Cognitive Sciences and Center for Visual Science, University of Rochester, Rochester, NY 14627, USA
    Neurobiol Aging 28:194-201. 2007
    ..83 and classification accuracies of 0.75-0.79. P3 and CNV components, as well as other, earlier ERP components, e.g. C145 and the memory "Storage" component, were useful in the discriminant functions...
  5. pmc Brain ERP components predict which individuals progress to Alzheimer's disease and which do not
    Robert M Chapman
    Department of Brain and Cognitive Sciences and Center for Visual Science at the University of Rochester, Rochester, NY 14627, USA
    Neurobiol Aging 32:1742-55. 2011
    ..Empirically obtained prediction accuracies rose to 94% when the computed posterior probabilities for individuals were 0.90 or higher (which was found for 40% of our MCI sample)...
  6. pmc Diagnosis of Alzheimer's disease using neuropsychological testing improved by multivariate analyses
    Robert M Chapman
    Brain and Cognitive Sciences and Center for Visual Science, University of Rochester, Rochester, NY 14627 0270, USA
    J Clin Exp Neuropsychol 32:793-808. 2010
    ....
  7. pmc Predicting conversion from mild cognitive impairment to Alzheimer's disease using neuropsychological tests and multivariate methods
    Robert M Chapman
    Brain and Cognitive Sciences and Center for Visual Science, University of Rochester, Rochester, NY 14627 0270, USA
    J Clin Exp Neuropsychol 33:187-99. 2011
    ..70-1.00), where the obtained prediction accuracy was more than 90%. The strength and reliability of this multivariate prediction method were tested by cross-validation and randomized resampling...

Research Grants5

  1. Cognitive Brain Activity: Aging and Dementia
    Robert Chapman; Fiscal Year: 2007
    ..Multivariate statistics are used to measure the ERP components and to develop functions that discriminate among the subject groups and predict AD among the MCI patients. ..